Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target

Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies

(2018) Alice Lee et al.   CANCER TREATMENT REVIEWS

A review of the value of human epidermal growth factor receptor 2 (HER2)-targeted therapies in breast cancer

(2018) N.A. Nixon et al.   EUROPEAN JOURNAL OF CANCER

Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma

(2018) Linlin Yan et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Epigenetic actions of environmental factors and promising drugs for cancer therapy (Review)

(2017) Zhong‑Tian Bai et al.   Oncology Letters

Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression

(2017) Yang Chen et al.   Scientific Reports

Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy

(2017) Roberto Chalela et al.   Journal of Thoracic Disease

Challenges and Strategies in Precision Medicine for Non-Small-Cell Lung Cancer

(2016) Joseph J. Sacco et al.   CURRENT PHARMACEUTICAL DESIGN

Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia

(2016) A-K Eisfeld et al.   LEUKEMIA

Chemical proteomics approaches for identifying the cellular targets of natural products

(2016) M. H. Wright et al.   NATURAL PRODUCT REPORTS

Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database

(2016) Hai-long Chen et al.   PLoS One

InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams

(2015) Henry Heberle et al.   BMC BIOINFORMATICS

Antroquinonol from Antrodia Camphorata suppresses breast tumor migration/invasion through inhibiting ERK-AP-1- and AKT-NF-κB-dependent MMP-9 and epithelial-mesenchymal transition expressions

(2015) Wai-Theng Lee et al.   FOOD AND CHEMICAL TOXICOLOGY

Relationship Between Tumor Size and Survival in Non–Small-Cell Lung Cancer (NSCLC): An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Registry

(2015) Jianjun Zhang et al.   Journal of Thoracic Oncology

Total Synthesis of (+)-Antroquinonol and (+)-Antroquinonol D

(2015) Rohidas S. Sulake et al.   ORGANIC LETTERS

The impact of the Cancer Genome Atlas on lung cancer

(2015) Jeremy T.-H. Chang et al.   Translational Research

Antroquinonol A: Scalable Synthesis and Preclinical Biology of a Phase 2 Drug Candidate

(2015) Matthew T. Villaume et al.   ACS Central Science

Antroquinonol blocks Ras and Rho signaling via the inhibition of protein isoprenyltransferase activity in cancer cells

(2014) Ching-Liang Ho et al.   BIOMEDICINE & PHARMACOTHERAPY

Antroquinonol D, Isolated from Antrodia camphorata, with DNA Demethylation and Anticancer Potential

(2014) Sheng-Chao Wang et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Total Synthesis of (±)-Antroquinonol D

(2014) Rohidas S. Sulake et al.   JOURNAL OF ORGANIC CHEMISTRY

International trends in lung cancer incidence by histological subtype: Adenocarcinoma stabilizing in men but still increasing in women

(2014) J. Lortet-Tieulent et al.   LUNG CANCER

Causal analysis approaches in Ingenuity Pathway Analysis

(2013) Andreas Krämer et al.   BIOINFORMATICS

DNMT1 modulates gene expression without its catalytic activity partially through its interactions with histone-modifying enzymes

(2012) Eriko G. Clements et al.   NUCLEIC ACIDS RESEARCH

Antroquinonol, a natural ubiquinone derivative, induces a cross talk between apoptosis, autophagy and senescence in human pancreatic carcinoma cells

(2011) Chia-Chun Yu et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

DNA methylation profile during multistage progression of pulmonary adenocarcinomas

(2011) Jin-Haeng Chung et al.   VIRCHOWS ARCHIV

Hypermethylation of CCND2 May Reflect a Smoking-Induced Precancerous Change in the Lung

(2011) Alexander Salskov et al.   Journal of Oncology

Methylated cyclin D2 gene circulating in the blood as a prognosis predictor of hepatocellular carcinoma

(2010) Masahito Tsutsui et al.   CLINICA CHIMICA ACTA

The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients

(2010) Ruo-Kai Lin et al.   JOURNAL OF CLINICAL INVESTIGATION

Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer

(2010) Mónica Castro et al.   Journal of Translational Medicine

Antroquinonol inhibits NSCLC proliferation by altering PI3K/mTOR proteins and miRNA expression profiles

(2010) V. Bharath Kumar et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: A crucial role of AMPK and mTOR pathways

(2009) Po-Cheng Chiang et al.   BIOCHEMICAL PHARMACOLOGY

Review of Pharmacological Effects ofAntrodia camphorataand Its Bioactive Compounds

(2009) Madamanchi Geethangili et al.   Evidence-based Complementary and Alternative Medicine